Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ParMed Pharmaceuticals is a leading distributor of generic pharmaceuticals, primarily serving independent retail pharmacies, hospitals, and healthcare providers across the United States. Founded in 1968 and headquartered in Niagara Falls, New York, the company established itself as a pioneer in the telemarketing-based wholesale model for generic drugs. In 2006, ParMed was acquired by Cardinal Health, a global leader in healthcare services, to bolster its generic distribution network and service offerings for independent pharmacies. The company provides an extensive portfolio of products, including generic prescription medications, over-the-counter products, and diagnostic supplies. ParMed is recognized for its commitment to helping independent pharmacies remain competitive through aggressive pricing, reliable supply chains, and dedicated customer support. Today, it operates as a specialized business unit within Cardinal Health’s pharmaceutical segment, leveraging the parent company's vast logistics infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ParMed Pharmaceuticals.